Company Overview

Update
Founded:
2004
Headquarters:
Melbourne
IPO:
Went Public on Mar 14, 2013
Stock:
MSB
Categories:
Biotechnology
Description:
Mesoblast Limited is a world leader in the development of biologic products for the broad field of regenerative medicine.

Detailed Description

Update

Mesoblast Limited is a world leader in the development of biologic products for the broad field of regenerative medicine. Mesoblast's patented Mesenchymal Precursor Cell (MPC) technology is being developed for an extensive range of major clinical diseases, including inflammatory and immunologic conditions of the joints and lungs, diabetes and kidney disease, orthopedic spine conditions, and cardiovascular disorders.

Current Team (4)

Update

Acquisitions (1)

Update

Offices/Locations (1)

Update
  • Office

    Level 39

    55 Collins Street

    Melbourne, 3000

    AUS